Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers.
Lionnet
F
F
Bachmeyer
C
C
Stankovic
K
K
Tharaux
P L
PL
Girot
R
R
Aractingi
S
S
D000755:Anemia, Sickle Cell / Q000150:complications*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D005260:Female; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy*; D008875:Middle Aged; D013449:Sulfonamides / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan